Bristol-Myers: raises annual targets
(CercleFinance.com) - Bristol-Myers Squibb has raised its target adjusted EPS range for 2018, to between 3.
80 dollars and 3.90 dollars, compared with 3.55 dollars to 3.65 dollars previously, for high single-digit growth in revenue.
In its third quarter, the pharmaceutical group reported EPS growth of 45% to 1.09 dollar, 18 cents higher than the consensus, for revenues that are up 8% to nearly 5.7 billion dollars.
Copyright (c) 2018 CercleFinance.com. All rights reserved.
80 dollars and 3.90 dollars, compared with 3.55 dollars to 3.65 dollars previously, for high single-digit growth in revenue.
In its third quarter, the pharmaceutical group reported EPS growth of 45% to 1.09 dollar, 18 cents higher than the consensus, for revenues that are up 8% to nearly 5.7 billion dollars.
Copyright (c) 2018 CercleFinance.com. All rights reserved.